PR Newswire·Jan 14, 2026, 8:30 AM ET

LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaign

LENZ Therapeutics, Inc. announced the "Make it VIZZable" campaign on Jan. 14, 2026, featuring Sarah Jessica Parker as brand ambassador for VIZZ (aceclidine ophthalmic solution) 1.44%.
VIZZ is a once-daily prescription eye drop designed to restore near vision for up to 10 hours as an alternative to reading glasses.
The drug utilizes aceclidine to contract the iris sphincter muscle, creating a pinhole effect that extends depth of focus without causing a myopic shift.
In the CLARITY Phase 3 clinical trial, 93% of participants achieved 20/40 or better near vision within 30 minutes.
The product is preservative-free, provided in single-dose vials, & available nationwide through eye doctors.
Common adverse reactions include instillation site irritation (20%), dim vision (16%), & headache (13%), with warnings regarding temporary dark vision & operating machinery.
Patients should remove contact lenses before application & wait 10 minutes before reinsertion.
The campaign highlights the convenience of clear near vision for daily tasks like reading text messages, scanning price tags, & reviewing scripts without glasses.
Presbyopia affects nearly all individuals over age 45, with adults over 50 losing an average of 1.5 lines of near vision every six years.
LENZ Therapeutics is headquartered in San Diego, California, & is commercializing VIZZ in the United States while establishing international licensing partnerships.